$1,199,591
-23.5%
President/Ceo RSFH (End 12/23)
2023
$1.1M related
49 hrs/wk
$94k other
--
President/Ceo RSFH (End 12/23) at Clinical Biotechnology Research Institute at RSFH
Fiscal year ended December 31, 2023. Published on January 25, 2026.
Total compensation
Jeffrey Dilisi, M.D. has been listed as an employee of Clinical Biotechnology Research Institute at RSFH in Form 990 filings since fiscal year 2020. Total compensation for Jeffrey Dilisi, M.D. has increased by 1,227.2% from 2020 to 2023.